OmniPod DASH Guide De L'utilisateur page 4

INDICATIONS FOR USE
The Omnipod DASH Insulin
Management System is intended
for subcutaneous delivery of
insulin at set and variable
rates for the management of
diabetes mellitus in persons
requiring insulin.
CONTRAINDICATIONS
Insulin pump therapy is NOT
recommended for people who are:
• Unable to monitor blood glucose
levels as recommended by their
healthcare provider
• Unable to maintain contact with
their healthcare provider
• Unable to use the
Omnipod DASH System
according to instructions
PDM Model PDM-INT2-D001-MM
To access the complete Omnipod DASH System
Technical User Guide
At any time while using Omnipod DASH, you can access or request the
Omnipod DASH Technical User Guide.
Download or print a digital copy:
1
- Scan this QR code with your smartphone
- Visit omnipod.com/guides
Request to receive a free printed copy:
2
- Call in to request one using the information on your contact card.
4
COMPATIBLE INSULINS
The Omnipod DASH System is
designed to use rapid-acting U-100
insulin. The following U-100 rapid-
acting insulin analogues have been
tested and found to be safe for use
in the Pod: NovoLog
aspart), Fiasp (insulin aspart),
®
Humalog (insulin lispro), Admelog
®
(insulin lispro) and Apidra
glulisine). NovoLog, Fiasp, Humalog
and Admelog are compatible with
the Omnipod DASH System for use
up to 72 hours (3 days). Apidra is
compatible with the Omnipod DASH
System for use up to 48 hours
(2 days).
If you have questions about
using other insulins, contact your
healthcare provider. Fiasp has a
faster initial absorption than other
rapid-acting U-100 insulins; always
consult with your healthcare
provider and refer to the insulin
labelling prior to use.
(insulin
®
®
(insulin
®